Status:

RECRUITING

Intermittent Hypoxia-Hyperoxia Combined With Physical Therapy for Knee Osteoarthritis

Lead Sponsor:

Khyber Medical University Peshawar

Collaborating Sponsors:

Rehman Medical Institute - RMI

Conditions:

Osteo Arthritis Knee

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of combining intermittent hypoxia-hyperoxia therapy (IHHT) with conventional physical therapy in improving pain, function, gait, bal...

Detailed Description

Osteoarthritis (OA) is a prevalent chronic condition that leads to joint pain, stiffness, and impaired mobility, particularly among middle-aged and elderly populations. In Pakistan, knee OA is common ...

Eligibility Criteria

Inclusion

  • Participants aged 45 and above.
  • Participants (both male and female) with knee pain for 3 months or more with any three of the following six items: age of 50 years or more, crepitations, enlarged bone, no palpable warmth, morning stiffness for less than 30 minutes, and bony tenderness.
  • Patients who can walk and have a minimum score of 4 on the Numeric Pain Rating Scale.
  • Participants who have intact cognition with a score of 24 and above on Mini Mini- Mental State examination.
  • Participants able to walk independently for at least 45 meters in the 6-minute walk test.
  • Participants having a recent X-ray (done within the past 3 months).

Exclusion

  • Patients with hip or knee arthroplasty.
  • Participants with above or below knee surgery or radiating pain to the lower limb.
  • Patients with history of epilepsy, pregnancy
  • Diagnosed neurological condition that affects lower-limb strength or walk (e.g., stroke/ basal ganglia dysfunction/ trauma)
  • Patients who refused to participate in the study or to be randomly allocated.
  • Patients receiving steroids or any medicine other than that prescribed by the screening orthopaedic surgeon.

Key Trial Info

Start Date :

May 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06965946

Start Date

May 15 2025

End Date

November 30 2025

Last Update

September 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rehman Medical Institute

Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000